Jane Street Group, LLC Alkermes Plc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Jane Street Group, LLC holds 261,628 shares of ALKS stock, worth $7.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

261,628

Previous 207,394 26.15%

Holding current value

$7.77 Million

Previous $5 Million 46.5%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $1.25 Million - $1.55 Million	54,234 Added 26.15%	261,628 $7.32 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $3.08 Million - $3.61 Million	132,636 Added 177.42%	207,394 $5 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $855,201 - $1.05 Million	-32,394 Reduced 30.23%	74,758 $2.02 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $24,024 - $29,483	1,028 Added 0.97%	107,152 $2.97 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $1.89 Million - $2.22 Million	-69,468 Reduced 39.56%	106,124 $2.97 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $2.18 Million - $2.59 Million	76,979 Added 78.06%	175,592 $5.5 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $1.53 Million - $1.75 Million	60,327 Added 157.57%	98,613 $2.78 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $839,994 - $1 Million	38,286 New	38,286 $1 Million
Q2 2022 Aug 16, 2022	BUY	$26.4 - $30.54 $1.24 Million - $1.44 Million	47,005 Added 134.58%	81,932 $2.44 Million
Q1 2022 May 17, 2022	SELL	$23.07 - $27.99 $17,833 - $21,636	-773 Reduced 2.17%	34,927 $919,000
Q3 2021 Nov 16, 2021	BUY	$23.37 - $32.13 $162,701 - $223,689	6,962 Added 24.23%	35,700 $1.1 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $283,408 - $379,538	15,091 Added 110.58%	28,738 $704,000
Q1 2021 May 18, 2021	SELL	$18.21 - $23.2 $682,929 - $870,069	-37,503 Reduced 73.32%	13,647 $255,000
Q4 2020 Feb 17, 2021	BUY	$15.39 - $22.1 $923 - $1,326	60 Added 0.12%	51,150 $1.02 Million
Q3 2020 Nov 17, 2020	BUY	$16.16 - $20.66 $451,768 - $577,570	27,956 Added 120.84%	51,090 $846,000
Q2 2020 Aug 17, 2020	BUY	$13.31 - $19.41 $171,086 - $249,496	12,854 Added 125.04%	23,134 $449,000
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $1.3 Million - $2.12 Million	-99,641 Reduced 90.65%	10,280 $148,000
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $1.61 Million - $2.02 Million	92,879 Added 545.0%	109,921 $2.24 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $332,489 - $413,779	17,042 New	17,042 $333,000
Q1 2019 May 16, 2019	SELL	$28.4 - $36.49 $480,641 - $617,556	-16,924 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$27.94 - $44.61 $891,788 - $1.42 Million	-31,918 Reduced 65.35%	16,924 $500,000
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $1.89 Million - $2.25 Million	48,842 New	48,842 $2.07 Million
Q2 2018 Aug 15, 2018	SELL	$40.56 - $51.36 $452,000 - $572,355	-11,144 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $597,429 - $749,545	11,144 New	11,144 $646,000

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Alkermes Plc. Transaction History